Antimalarial drug chloroquine counteracts activation of indoleamine (2,3)-dioxygenase activity in human PBMC.
about
Chloroquine inhibits Ca2+ permeable ion channels-mediated Ca2+ signaling in primary B lymphocytesThe potential of targeting indoleamine 2,3-dioxygenase for cancer treatment.Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy.Inhibition of autophagy by chloroquine induces apoptosis in primary effusion lymphoma in vitro and in vivo through induction of endoplasmic reticulum stress.
P2860
Antimalarial drug chloroquine counteracts activation of indoleamine (2,3)-dioxygenase activity in human PBMC.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Antimalarial drug chloroquine ...... genase activity in human PBMC.
@en
Antimalarial drug chloroquine ...... genase activity in human PBMC.
@nl
type
label
Antimalarial drug chloroquine ...... genase activity in human PBMC.
@en
Antimalarial drug chloroquine ...... genase activity in human PBMC.
@nl
prefLabel
Antimalarial drug chloroquine ...... genase activity in human PBMC.
@en
Antimalarial drug chloroquine ...... genase activity in human PBMC.
@nl
P2093
P2860
P1433
P1476
Antimalarial drug chloroquine ...... genase activity in human PBMC.
@en
P2093
Dietmar Fuchs
Florian Uberall
Harald Schennach
Johanna M Gostner
Kathrin Becker
Marcel Jenny
Sebastian Schröcksnadel
P2860
P304
P356
10.1016/J.FOB.2012.08.004
P577
2012-08-17T00:00:00Z